« Previous
Next »
Nutrition, Metabolism & Cardiovascular Diseases
Volume 19, Issue 9
, Pages 641-645
, November 2009
Magnesium administration may improve heart rate variability in patients with heart failure
References
- . Fractal variability versus pathologic periodicity: complexity loss and stereotypy in disease. Perspect Biol Med. 1997;40:543–561
- Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98:1510–1516
- . Heart rate variability in myocardial infarction and heart failure. Int J Cardiol. 2007;120:289–296
- Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol. 2002;90:24–28
- . Measures of heart period variability as predictors of mortality in hospitalized patients with decompensated congestive heart failure. Am J Cardiol. 2004;93:59–63
- . Measuring the strangeness of strange attractors. Physica D. 1983;9:189–208
- . Chaos theory, heart rate variability, and arrhythmic mortality. Circulation. 2000;101:8–10
- The application of methods of non-linear dynamics for the improved and predictive recognition of patients threatened by sudden cardiac death. Cardiovasc Res. 1996;31:419–433
- Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure. J Card Fail. 2007;13:294–303
- . Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond). 2008;114:243–249
- . Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF–HRV registry. Pacing Clin Electrophysiol. 2007;30:56–64
- . Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure. Am Heart J. 2004;148:e16
- Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation. 2004;109:990–996
- Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure. Int Heart J. 2006;47:565–573
- . Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis. 1994;24:737–752
- . Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem. 2002;238:163–179
- . Electrolyte balance in heart failure and the role for magnesium ions. Am J Cardiol. 1992;70:44C–49C
- . Significance of magnesium in congestive heart failure. Am Heart J. 1996;132:664–671
- . Influence of autonomic nervous system on electrolyte abnormalities in children with mitral valve prolapse. Pol Merkur Lekarski. 2003;14:220–223
- Effects of chronic sleep deprivation on autonomic activity by examining heart rate variability, plasma catecholamine, and intracellular magnesium levels. Biomed Pharmacother. 2004;58:S35–S39
- Cell-associated magnesium and QT dispersion in hemodialysis patients. Am J Kidney Dis. 2003;41:196–202
- . Magnesium metabolism: a review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med. 1988;148:2415–2420
- . Modulation of CaV1.2 channels by Mg2+ acting at an EF-hand motif in the COOH-terminal domain. J Gen Physiol. 2005;126:311–323
- . Autonomic nerve activity and atrial fibrillation. Heart Rhythm. 2007;4:S61–S64
- . Low blood mononuclear cell magnesium in intensive cardiac care unit patients. Am Heart J. 1986;111:475–480
- . Clinical characteristics of patients with increased urinary excretion of adrenaline in mild to moderate heart failure. Clin Cardiol. 2001;24:209–213
- . Magnesium dynamics and sympathetic nervous system activity in patients with chronic heart failure. Jpn Circ J. 1999;63:267–273
- . Real-time heart rate variability and its correlation with plasma catecholamines during laparoscopic adrenal pheochromocytoma surgery. Anesth Analg. 2008;106:164–170
- Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J. 1999;20:111–120
- Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1993;72:1156–1162
- . Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation. 2000;102:2353–2358
- An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence. Ann Noninvasive Electrocardiol. 2006;11:163–169
PII: S0939-4753(08)00234-2
doi: 10.1016/j.numecd.2008.12.002
© 2008 Elsevier B.V. All rights reserved.
« Previous
Next »
Nutrition, Metabolism & Cardiovascular Diseases
Volume 19, Issue 9
, Pages 641-645
, November 2009
